BF
AGIO icon

BOK Financial’s Agios Pharmaceuticals AGIO Stock Holding History

BOK Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,813
Closed -$785K – 894
2016
Q4 		$785K Sell
18,813
-456
-2% -$23.9K 0.03% 525
2016
Q3 		$1.02M Buy
+19,269
New +$839K 0.03% 472

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BOK Financial's AGIO Position: Q1 2017 in Review

BOK Financial sold out of Agios Pharmaceuticals (AGIO) in Q1 2017, closing a stake of 18,813 shares — an estimated $785K sold.

BOK Financial first reported a position in AGIO in Q3 2016 and held it in 2 quarters. The position peaked at $1.02M in Q3 2016. 156 funds tracked by Wall St. Rank hold AGIO as of Q1 2017.

  • BOK Financial reported no remaining Agios Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • BOK Financial sold 18,813 Agios Pharmaceuticals shares in Q1 2017, an estimated $785K.
  • BOK Financial first reported a position in Agios Pharmaceuticals in Q3 2016 and held it in 2 quarters.
  • BOK Financial's Agios Pharmaceuticals position peaked at $1.02M in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2017.

Based on BOK Financial's 13F filing for Q1 2017, filed 15 May 2017.